Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Vifa2g03937 ATGAGTAGCTTGGTTGAGAGGCTTCGCGTAAGATCAGAACGCAAGCCAGTTTATAATATTGATGAGTCAGATGATGATGATTTTTTACTTAAGAAACCTGGGACAAGCCAGGATAAGTTTGAGAGGATAGCCAGAAGTGATGCAAAAGAGGATTTATGTCAAGCCTGTGGTGAAAGTGAAGGTCTCCTGAGTTGTGAAACTTGCACCTATGCTTACCATTCTAGGTGTTTACTTCCACCACTTAAAGGTCCTTCTCCCGACAGCTGGAGGTGCCCTGAATGTGTTAGCCCCCTTACTGATATTGATAAGATATTAGACTGTGAGATGCGCCCTACTCAAGACAGTGATGGTGATGGCGAGGGCGATGGCGATGGTGACACCACAAAATCTGGGTCAAAGCAAATTTTTGTTAAACAATACCTTGTTAAGTGGAAGGCACTATCTTATCTGCATTGTGCATGGGTGCCAGAGAAAGAGTTTCTGAAAGCTTTTAAGAATCATCCTCGTCTGAAGACCAAAGTGAACAACTTCCACCGTCAAATGTCTTCTGCAAATACTTCAGATGACGACTTTGTTGCCATCCGCCCTGAATGGACTACAGTTGATCGAATAATTGCTTGCAGGGGTGATAGCGATGAGAGGGAATATCTGGTGAAGTGGAAAGAGCTTTCATATGACGAATGTTATTGGGAATCTGAGTCTGATATCTCAGCATTTCAGCCGGAAATAGAAAGATTCAATAGATTTCGTTCTAGATCGAGCAAGCTTGCTTTCATTAAGCAAAAAAGCCGTGTTGATGTTGACACTGAATTGAAGAAACAGCAGAAAGAATTTCAACAGTATGAACATAGCCCCAAGTTTCTTTCAGGTTCTCTACACCCATATCAGCTTGAAGGTTTGAACTTCTTACGATTCTCTTGGTCCAAGCAGACACATGTTATACTTGCTGATGAGATGGGACTTGGAAAAACTATTCAGAGTATTGCTTTCTTAGCATCCCTTTTTGAAGAGGGTGTCTCTAAACACCCACATCTGGTGGTTGCTCCACTTTCAACACTGCGAAACTGGGAACGTGAATTTGCAACATGGGCCCCTCAGATGAATGTTATTATGTATGTTGGATCTGCCCAAGCTCGTAGTGTTATCAGAGAATATGAATTTTTCTTTCCCAAGAAAATGAAGAAGTTAAAGAAAAAGAAATCTGGTCAGATAGTTGGCGAAAGTAAGCATGACAGAATAAAGTTTGATGTCCTTTTGACATCATATGAGATGATCAACTTGGACACAACATCATTAAAACCTATAAAATGGGAGTGCATGATAGTCGATGAAGGTCACCGCCTCAAAAATAAGGATTCAAAATTATTTTCTTCTTTGAAGCAATATATTACCAGACATCGTGTTCTCCTGACCGGAACTCCTCTTCAGAACAACTTGGATGAGCTTTTTATGCTTATGCATTTCCTTGATGCTGGAAAGTTTGGAAGTTTAGAGGAATTCCAAGAAGAATTCAAGGATATCAATCAAGAGGAACAGATTTCGAGGCTTCATAAAATGCTGGCACCGCATCTTCTGCGAAGAGTGAAGAAAGATGTCATGAAGGAACTACCTCCTAAAAAGGAACTTATTCTACGAGTTGATTTGAGCAGCAAACAGAAAGAATATTATAAGGCAATTTTGACCCGTAATTATCAGATATTAACTCGCCGTGGCGGTGCACAGATTTCTCTTATCAATGTTGTTATGGAACTGCGTAAGCTCTGTTGTCACGCTTACATGTTAGAAGGAGTTGAGCCAGATATTGACGATCCAAAAGAAGCATTCAAACAATTGTTGGAATCATCTGGGAAGTTGCACTTGCTGGACAAGATGATGGTGAAGCTTAAAGAGCAAGGACATAGAGTTCTTATATACACCCAATTTCAGCACATGCTTGATTTGCTTGAAGATTATTGCTCTTACAAGAAATGGCAGTATGAAAGGATAGATGGCAAGGTTGGTGGAGCTGAAAGACAAATACGGATAGATCGTTTTAATGCCAAAAATTCTTCAAGATTTTGCTTTCTTCTTTCTACCAGAGCTGGGGGTTTGGGGATAAACCTTGCAACTGCTGACACAGTTGTTATATATGACAGTGATTGGAATCCTCATGCTGACTTACAAGCAATGGCTAGAGCTCATCGACTTGGACAAACTAACAAGGTGTTGATTTATAGGCTTGTAACAAGAGGAACAATTGAAGAAAGGATGATGCAAATGACTAAGAAGAAAATGGTGTTAGAACACCTTGTTGTAGGAAGGCTAAAGGCTCAAAATATCAACCAGGAAGAGCTGGATGACATTATACGGTATGGCTCAAAGGAGTTATTTGCAGATGAGAATGATGAAGCAGGAAAATCCCGTCAAATCCATTATGATGCAGCTGCTATCGATAGGTTGCTGGATCGTGACCAAGTTGTTGATGAAGATACTACTTTGGATGATGAAGAGGAAGATGGATTTCTGAAGGCCTTTAAGGTTGCAAATTTTGAGTATGTTGATGAGGCTGAGGCTGCAGCAGAAGCTGCAGCAGAGGAGGCAGCACAAAAAAGAGCAATGGAAACTGTGAACAGTTCAGAAAGAACACATTATTGGGAAGAGTTGTTAAAGGATAAGTTTCAAGAGCATAAAGTTGAGGAGTTTAATGCTTTGGGCAAAGGAAAGCGAAACCGCAAGTTGATGGTTTCCGTTGAGGAGGACGACCTTGCTGGTTTGGAAGATGTAAGCTCCGACGAAGACGACAATTATGAGGCAGAGCTTACTGATGGTGACTCAAATTCCACTGGAACTACTTCTAGTAGAAGGCCTTATAAGAAAAAAGCACGCACGGATAGCGCAGAGCCACTTCCTCTGATGGAAGGTGAAGGAAAAGCATTCAGAGTACTTGGTTTTAATCAAAATCAGAGGGCTGCCTTTGTGCAAATTTTGATGAGGTTTGGGGTTGGTGATTTTGATTGGAAGGAGTTTACTTCCCGCATGAAACAGAAGACATATGAAGAAATCAAAGATTATGGAACCCTTTTCTTGTCTCACATTGCTGAAGATATAACTGATTCCTCTACATTCACAGATGGTGTTCCAAAAGAAGGACTCCGAATCCAAGATGTACTTGTTAGGATTGCAGTCCTGCTCTTGTTAAGGGACAAAGTGAGGTTTGCATCGGAATATCCTCGTACTCCACTGTTTTCAGATGACATCTTATTACGTTATCCGGGTTTGAAGGGTGTAAGGAAGTGGAAGGAGGAGCATGATCTTTTGCTACTGCGTGCTGTGTTAAAGCATGGGTATGGAAGGTGGCAAGCTATTGTAGATGATAAGGATCTGAAGATTCAGGAGATCATCTGCCAGGAGTTGAATCTTCCCGTTATAAATTTACCAGGACCAGGACAAGTTGGCTCTCATGTACAAAATGGCGCGAATTTGGCAAATGCAGAAATACCCAGCAATGAATCCAGGGAAAATGGTGGAAGTGACATAGCAGCTGATGGTGCACAGGGTTCAAGCGATGCTAGGAATCAACCACAGCTATATCAAGACTCGTCCATGATATATCATTTTAGAGACATGCAAAGAAGACAGGTTGAGTTTGTAAAGAAGAGGGTTCTTCTTTTGGAAAAGGGGCTCAATGCTGAGTACCAGAAAGAATACTTTGGTGATCCAAAAGCTGGCGAAGTAACCAATGAAGAACTTAAAAGTGAACTCAAGTCTACCAGTGTTCCAAGTTATAAATCAGTGGATACTAATACCCAAATGGTTGATCAATTGCCACAAGTAGAAACCATAGCTCCAGGAGATGTTTCAGTTGCTTGTGATAGTGATCCAAATCGATTGGAGTTAGTTCGACTTTACAACGAGATGTGCAAGGTAGTTGAGGAAAACCCCATGGATTTAGTTCAAGCTTCATTGGCAGGAGAACCGGCAGAGGTCAATGCAGGGAAGAAGTTTCAGCCTCTAGAGGCCATCAGTGAAAGCATCAACAGAATCCTAACACCCACAGTAGCAGAAACTCCAATATTAAATTCAGACAACAAATCAGAGGCTACCCCTCAAAATGACTGCAAACTTAATTCTTCAGCAGATGACAAGACTCAAGACATGGTAATCGAATGTGATCCTATAAAAGAAAGCTGCTCAAGCCTCGTAAATGAGAACAAGGAAACACCCGATAAAAAGGAAAGCAATACTGAGATGGATGAAAGTCATGCTGAGTTGAATGAGAATTCTGGTGCTGGAGTCATTGTATTGGATGAGTAA 4293 0.4116 MSSLVERLRVRSERKPVYNIDESDDDDFLLKKPGTSQDKFERIARSDAKEDLCQACGESEGLLSCETCTYAYHSRCLLPPLKGPSPDSWRCPECVSPLTDIDKILDCEMRPTQDSDGDGEGDGDGDTTKSGSKQIFVKQYLVKWKALSYLHCAWVPEKEFLKAFKNHPRLKTKVNNFHRQMSSANTSDDDFVAIRPEWTTVDRIIACRGDSDEREYLVKWKELSYDECYWESESDISAFQPEIERFNRFRSRSSKLAFIKQKSRVDVDTELKKQQKEFQQYEHSPKFLSGSLHPYQLEGLNFLRFSWSKQTHVILADEMGLGKTIQSIAFLASLFEEGVSKHPHLVVAPLSTLRNWEREFATWAPQMNVIMYVGSAQARSVIREYEFFFPKKMKKLKKKKSGQIVGESKHDRIKFDVLLTSYEMINLDTTSLKPIKWECMIVDEGHRLKNKDSKLFSSLKQYITRHRVLLTGTPLQNNLDELFMLMHFLDAGKFGSLEEFQEEFKDINQEEQISRLHKMLAPHLLRRVKKDVMKELPPKKELILRVDLSSKQKEYYKAILTRNYQILTRRGGAQISLINVVMELRKLCCHAYMLEGVEPDIDDPKEAFKQLLESSGKLHLLDKMMVKLKEQGHRVLIYTQFQHMLDLLEDYCSYKKWQYERIDGKVGGAERQIRIDRFNAKNSSRFCFLLSTRAGGLGINLATADTVVIYDSDWNPHADLQAMARAHRLGQTNKVLIYRLVTRGTIEERMMQMTKKKMVLEHLVVGRLKAQNINQEELDDIIRYGSKELFADENDEAGKSRQIHYDAAAIDRLLDRDQVVDEDTTLDDEEEDGFLKAFKVANFEYVDEAEAAAEAAAEEAAQKRAMETVNSSERTHYWEELLKDKFQEHKVEEFNALGKGKRNRKLMVSVEEDDLAGLEDVSSDEDDNYEAELTDGDSNSTGTTSSRRPYKKKARTDSAEPLPLMEGEGKAFRVLGFNQNQRAAFVQILMRFGVGDFDWKEFTSRMKQKTYEEIKDYGTLFLSHIAEDITDSSTFTDGVPKEGLRIQDVLVRIAVLLLLRDKVRFASEYPRTPLFSDDILLRYPGLKGVRKWKEEHDLLLLRAVLKHGYGRWQAIVDDKDLKIQEIICQELNLPVINLPGPGQVGSHVQNGANLANAEIPSNESRENGGSDIAADGAQGSSDARNQPQLYQDSSMIYHFRDMQRRQVEFVKKRVLLLEKGLNAEYQKEYFGDPKAGEVTNEELKSELKSTSVPSYKSVDTNTQMVDQLPQVETIAPGDVSVACDSDPNRLELVRLYNEMCKVVEENPMDLVQASLAGEPAEVNAGKKFQPLEAISESINRILTPTVAETPILNSDNKSEATPQNDCKLNSSADDKTQDMVIECDPIKESCSSLVNENKETPDKKESNTEMDESHAELNENSGAGVIVLDE 1430
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Vifa2g03937 1430 MobiDBLite consensus disorder prediction 109 130 - -
Vifa2g03937 1430 Gene3D - 289 536 IPR038718 -
Vifa2g03937 1430 Pfam CHD subfamily II, DUF1087 856 914 IPR009463 -
Vifa2g03937 1430 SUPERFAMILY Chromo domain-like 191 249 IPR016197 -
Vifa2g03937 1430 CDD CD1_tandem 101 179 - -
Vifa2g03937 1430 SMART helicmild6 646 730 IPR001650 -
Vifa2g03937 1430 Pfam SNF2-related domain 312 593 IPR000330 GO:0005524|GO:0140658
Vifa2g03937 1430 CDD SF2_C_SNF 615 741 - -
Vifa2g03937 1430 SMART chromo_7 98 175 IPR000953 -
Vifa2g03937 1430 SMART chromo_7 197 251 IPR000953 -
Vifa2g03937 1430 ProSiteProfiles Chromo and chromo shadow domain profile. 199 248 IPR000953 -
Vifa2g03937 1430 ProSiteProfiles Chromo and chromo shadow domain profile. 99 189 IPR000953 -
Vifa2g03937 1430 PANTHER CHROMODOMAIN-HELICASE-DNA-BINDING PROTEIN 3-RELATED-RELATED 44 1404 - -
Vifa2g03937 1430 Pfam PHD-finger 53 95 IPR019787 -
Vifa2g03937 1430 Coils Coil 846 866 - -
Vifa2g03937 1430 MobiDBLite consensus disorder prediction 1352 1375 - -
Vifa2g03937 1430 MobiDBLite consensus disorder prediction 1392 1430 - -
Vifa2g03937 1430 Pfam Helicase conserved C-terminal domain 618 730 IPR001650 -
Vifa2g03937 1430 SMART PHD_3 52 95 IPR001965 -
Vifa2g03937 1430 MobiDBLite consensus disorder prediction 1397 1416 - -
Vifa2g03937 1430 Gene3D - 1047 1223 - -
Vifa2g03937 1430 SMART DUF1086_2 923 1080 IPR009462 GO:0003677|GO:0006338
Vifa2g03937 1430 Gene3D Zinc/RING finger domain, C3HC4 (zinc finger) 43 98 IPR013083 -
Vifa2g03937 1430 ProSitePatterns Zinc finger PHD-type signature. 53 94 IPR019786 -
Vifa2g03937 1430 ProSiteProfiles Zinc finger PHD-type profile. 50 97 IPR019787 -
Vifa2g03937 1430 MobiDBLite consensus disorder prediction 109 127 - -
Vifa2g03937 1430 SMART DUF1087_2 851 917 IPR009463 -
Vifa2g03937 1430 SMART ultradead3 288 503 IPR014001 -
Vifa2g03937 1430 Gene3D - 537 761 IPR027417 -
Vifa2g03937 1430 Pfam CHD subfamily II, SANT-like domain 944 1077 IPR009462 GO:0003677|GO:0006338
Vifa2g03937 1430 MobiDBLite consensus disorder prediction 916 962 - -
Vifa2g03937 1430 SUPERFAMILY P-loop containing nucleoside triphosphate hydrolases 279 527 IPR027417 -
Vifa2g03937 1430 ProSiteProfiles Superfamilies 1 and 2 helicase ATP-binding type-1 domain profile. 304 492 IPR014001 -
Vifa2g03937 1430 ProSiteProfiles Superfamilies 1 and 2 helicase C-terminal domain profile. 620 781 IPR001650 -
Vifa2g03937 1430 SUPERFAMILY P-loop containing nucleoside triphosphate hydrolases 529 785 IPR027417 -
Vifa2g03937 1430 CDD CD2_tandem 197 248 - -
Vifa2g03937 1430 MobiDBLite consensus disorder prediction 916 933 - -
Vifa2g03937 1430 Pfam Chromo (CHRromatin Organisation MOdifier) domain 127 165 IPR023780 -
Vifa2g03937 1430 Pfam Chromo (CHRromatin Organisation MOdifier) domain 200 248 IPR023780 -
Vifa2g03937 1430 SUPERFAMILY Chromo domain-like 65 184 IPR016197 -
Vifa2g03937 1430 Gene3D - 191 248 - -
Vifa2g03937 1430 Gene3D - 99 182 - -
Vifa2g03937 1430 MobiDBLite consensus disorder prediction 1159 1186 - -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Vifa2g03937 Vifa-Chr2 1152219586 1152238286 Dispersed/Tandem
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Vifa2g03937 609 781 RAD5 or RAD16-like Gene Family AT5G22750 31.792 2.82e-22 102
       

Transcription factors information

Select Regulatory Factors Family Gene Hmm_acc Hmm_name E_value Clan
TR PHD Vifa2g03937 SNF2_N 1.1e-65 CL0023
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Vifa2g03937 K11643 - gmx:100790230 2364.73